Literature DB >> 10590428

Prenatal diagnosis of congenital parvovirus B19 infection: value of serological and PCR techniques in maternal and fetal serum.

D Dieck1, R L Schild, M Hansmann, A M Eis-Hübinger.   

Abstract

Intrauterine infection with parvovirus B19 (B19) is associated with non-immune hydrops fetalis, miscarriage and stillbirth. Accurate laboratory tests for diagnosis of B19 infection are required to exclude other diagnoses. We analysed the diagnostic value of B19 IgM antibody testing and polymerase chain reaction (PCR) in the sera from 57 patients and their fetuses with abnormal ultrasonography. Viral DNA was found in 16 of the 58 fetuses (one twin pregnancy) whereas only 7 of these were tested positive for B19 IgM antibodies. The sera of all 16 mothers were also positive for B19 DNA. False-positive B19 IgM results were obtained from two fetuses. The study highlights the limitations of B19 IgM serology and shows for the first time that, if a sensitive PCR assay is used, DNA measurement is the best indicator of infection not only in the fetal blood but also in the maternal blood. This improves the diagnostic value of the laboratory results considerably. DNA assays are essential in cases of doubtful serological results. Copyright 1999 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10590428

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  7 in total

Review 1.  Parvovirus B19 infection in human pregnancy.

Authors:  R F Lamont; J D Sobel; E Vaisbuch; J P Kusanovic; S Mazaki-Tovi; S K Kim; N Uldbjerg; R Romero
Journal:  BJOG       Date:  2010-10-13       Impact factor: 6.531

2.  Determinants of orofacial clefting II: Effects of 5-Aza-2'-deoxycytidine on gene methylation during development of the first branchial arch.

Authors:  Ratnam S Seelan; Partha Mukhopadhyay; Dennis R Warner; Irina A Smolenkova; M Michele Pisano; Robert M Greene
Journal:  Reprod Toxicol       Date:  2016-12-05       Impact factor: 3.143

3.  High-sensitivity PCR detection of parvovirus B19 in plasma.

Authors:  P Daly; A Corcoran; B P Mahon; S Doyle
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

4.  New LightCycler PCR for rapid and sensitive quantification of parvovirus B19 DNA guides therapeutic decision-making in relapsing infections.

Authors:  T C Harder; M Hufnagel; K Zahn; K Beutel; H J Schmitt; U Ullmann; P Rautenberg
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

5.  Gestational and fetal outcomes in B19 maternal infection: a problem of diagnosis.

Authors:  Francesca Bonvicini; Chiara Puccetti; Nunzio C M Salfi; Brunella Guerra; Giorgio Gallinella; Nicola Rizzo; Marialuisa Zerbini
Journal:  J Clin Microbiol       Date:  2011-08-17       Impact factor: 5.948

6.  Long term follow up of serostatus after maternofetal parvovirus B19 infection.

Authors:  J Dembinski; A M Eis-Hübinger; J Maar; R Schild; P Bartmann
Journal:  Arch Dis Child       Date:  2003-03       Impact factor: 3.791

7.  Detection of human parvovirus B19 nonstrutural protein DNA by nested-polymerase chain reaction in gravida serum and pregnant tissues.

Authors:  Ting Shen; Yongmei Huang; Fuyuan Qiao; Zengqing Li; Haiyi Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2006
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.